Co-Diagnostics, Inc. (CODX) News

Co-Diagnostics, Inc. (CODX): $3.10

0.04 (+1.31%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter CODX News Items

CODX News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

CODX News Highlights

  • CODX's 30 day story count now stands at 6.
  • Over the past 15 days, the trend for CODX's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
  • The most mentioned tickers in articles about CODX are DX, CM and AMP.

Latest CODX News From Around the Web

Below are the latest news stories about CO-DIAGNOSTICS INC that investors may wish to consider to help them evaluate CODX as an investment opportunity.

Co-Diagnostics Third Quarter 2022 Earnings: Misses Expectations

Co-Diagnostics ( NASDAQ:CODX ) Third Quarter 2022 Results Key Financial Results Revenue: US$5.09m (down 83% from 3Q...

Yahoo | November 16, 2022

Co-Diagnostics, Inc. to Host Booth at MEDICA 2022 Trade Fair in Düsseldorf, Germany

Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be hosting a booth this week at the MEDICA 2022 trade fair in Düsseldorf, Germany from 15-17 November.

Yahoo | November 14, 2022

Co-Diagnostics, Inc.'s (NASDAQ:CODX) Intrinsic Value Is Potentially 23% Below Its Share Price

In this article we are going to estimate the intrinsic value of Co-Diagnostics, Inc. ( NASDAQ:CODX ) by estimating the...

Yahoo | November 12, 2022

Co-Diagnostics, Inc. Reports Third Quarter 2022 Financial Results

Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today financial results for the third quarter ended September 30, 2022.

Yahoo | November 10, 2022

Co-Diagnostics, Inc. to Host Booth at AMP This Week in Phoenix, AZ

Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that the Company is hosting a booth this week at the Association for Molecular Pathology ("AMP") annual expo, held November 1-5 in Phoenix, AZ.

Yahoo | November 3, 2022

Co-Diagnostics, Inc. Appoints Dr. Mark Poritz as New Chief Scientific Officer

Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx™" or the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it is pleased to welcome Mark Poritz, PhD as the Company's new Chief Scientific Officer ("CSO").

Yahoo | November 1, 2022

CO-DIAGNOSTICS, INC. ANNOUNCES THIRD QUARTER 2022 EARNINGS RELEASE DATE AND WEBCAST

Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today it will release its third quarter 2022 results on Thursday, November 10, 2022, after the market close. The Company will also host a conference call and webcast on the same day at 4:30 p.m. EDT to discuss its financial results with analysts and institutional investors. Management on the call will include Dwight Egan, Chief Executi

Yahoo | October 27, 2022

Co-Diagnostics, Inc. to Host Booth at Medlab Africa on Oct 26-28 in South Africa

Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that the Company will be hosting a booth this week at Africa Health/Medlab Africa in Johannesburg, South Africa on October 26-28, 2022.

Yahoo | October 26, 2022

Co-Diagnostics, Inc. to Host Booths at Conferences in Washington, D.C. and Bangkok, Thailand

Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that the Company will be hosting booths this week at IDWeek 2022 in Washington, D.C., and at Asia Health/Medlab Asia in Bangkok, Thailand.

Yahoo | October 19, 2022

Co-Diagnostics' (NASDAQ:CODX) investors will be pleased with their strong 225% return over the last three years

The last three months have been tough on Co-Diagnostics, Inc. ( NASDAQ:CODX ) shareholders, who have seen the share...

Yahoo | October 14, 2022


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6099 seconds.